DC
CYCN icon

Diametric Capital’s Cyclerion Therapeutics CYCN Stock Holding History

Diametric Capital’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,186
Closed -$210K – 318
2022
Q3 		$210K Buy
12,186
+9
+0.1% +$155 0.11% 216
2022
Q2 		$134K Buy
12,177
+3,030
+33% +$43.4K 0.1% 219
2022
Q1 		$203K Buy
9,147
+4,123
+82% +$99.3K 0.11% 186
2021
Q4 		$173K Buy
5,024
+1,533
+44% +$72.4K 0.13% 139
2021
Q3 		$214K Sell
3,491
-526
-13% -$34.4K 0.17% 112
2021
Q2 		$313K Buy
+4,017
New +$252K 0.23% 97

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return